Jaguar Health (JAGX) Preferred Stock Liabilities (2014 - 2026)

Jaguar Health (JAGX) has 9 years of Preferred Stock Liabilities data on file, last reported at $9.5 million in Q1 2026.

• On a quarterly basis, Preferred Stock Liabilities rose 281.09% year-over-year to $9.5 million in Q1 2026; TTM through Mar 2026 was $9.5 million, a 281.09% increase from a year earlier, with the FY2024 full-year figure at $2.5 million, changed N/A from the prior year.
• Preferred Stock Liabilities for Q1 2026 stood at $9.5 million, up from $2.5 million in the prior quarter.
• Over the last five years, Preferred Stock Liabilities for JAGX reached as high as $9.5 million in Q1 2026 and fell as low as $2.5 million in Q1 2024.
• Historically, Preferred Stock Liabilities has averaged $3.6 million across 3 years, with a median of $2.5 million in 2024.
• Across the five-year window, Preferred Stock Liabilities changed 0.0% in 2025 and surged 281.09% in 2026, its largest moves.
• Year by year, Preferred Stock Liabilities stood at $2.5 million in 2024, then changed by 0.0% to $2.5 million in 2025, then jumped by 281.09% to $9.5 million in 2026.
• Per Business Quant data, the three most recent Preferred Stock Liabilities figures were $9.5 million in Q1 2026, $2.5 million in Q1 2025, and $2.5 million in Q4 2024.